SEC Form 4 · accession 0001395064-26-000246
TAKEDA PHARMACEUTICAL CO LTD · TAK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julie So-Young Kim
Officer — President and CEO · Director
Period of report
Jul 1, 2026
Accepted (ET)
Jul 6, 2026 · 6:02 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001395064
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Jul 1, 2026 | A | 50,434 | $0.00 | A | 480,579 | D | |
| Ordinary Shares | Jul 1, 2026 | A | 22,800 | $0.00 | A | 22,800 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax Obligation AwardF3 | — | Jul 1, 2026 | A | 7,741 | A | Jun 1, 2027 | Jun 1, 2027 | Ordinary Shares | 7,741 | 7,741 | D |
| Tax Obligation AwardF3 | — | Jul 1, 2026 | A | 7,741 | A | Jun 1, 2028 | Jun 1, 2028 | Ordinary Shares | 7,741 | 7,741 | D |
| Tax Obligation AwardF3 | — | Jul 1, 2026 | A | 7,743 | A | Jun 1, 2029 | Jun 1, 2029 | Ordinary Shares | 7,743 | 7,743 | D |
Explanation of responses
- F1Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.
- F2Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest in three equal annual installments beginning on June 1, 2027.
- F3Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.